Cookies ensure the smooth running of our services. Using Univadis, you accept the use of cookies. Learn more.

Univadis - a service form MSD

A trusted medical reference

Create an account Log in

app catalog Search

Log in

Close

My Account

Loading...

Medical News Just Published Delete The JAMA Network Delete eLearning Medical Quiz Conference Reports Delete Radiology Collection Delete Oncology MSD Manual Delete Image & Media Library Delete Link Library PubMed Delete FRAX Delete Patient Resource Center Medical Calculators Explore
new apps

See all my apps Hide my apps

Explore new apps Manage my apps

Rearrange your apps by dragging them or delete them with the cross.

Save Cancel

Welcome. Please log in or create an account.

Log in

Remember me (Uncheck if on a shared computer)

Forgot your Password ?

Please review the fields marked in red and resubmit the form

Create an account

Register to access independent medical news and resources from Univadis^®

Latest updates

Medical News

Several countries have approved durvalumab as consolidation therapy for unselected unresectable stage III non-small cell lung cancer.

Experts criticise EMA decision to restrict use of durvalumab

Univadis Medical News
Thursday 17 January 2019

Several countries have approved durvalumab as consolidation therapy for unselected unresectable stage III non-small cell lung cancer.

The World Health Organization has published a list of 10 issues that will demand the attention of the organisation and health partners this year.

Ten threats to global health in 2019

Univadis Medical News
Thursday 17 January 2019

The World Health Organization has published a list of 10 issues that will demand the attention of the organisation and health partners this year.

Findings from a new randomised controlled trial.

Ulcerative colitis: faecal microbiota transplantation with anaerobically prepared stool

Univadis Medical News
Thursday 17 January 2019

Findings from a new randomised controlled trial.

More Medical News >

Conference Reports

Bleeding-related events and rescue medicine use are lower.

Eltrombopag shows advantage for ITP | ASH

Conference reports - RSi Communications
Monday 18 December 2017

Bleeding-related events and rescue medicine use are lower.

Hypertension was reported in 52.0% and diabetes in 13.3%; average BMI was 28.1.

HTN, DM, viral infection are CKD risk factors most often reported by older men with hemophilia | ASH

Conference reports - RSi Communications
Monday 18 December 2017

Hypertension was reported in 52.0% and diabetes in 13.3%; average BMI was 28.1.

Older adults’ concern about HU questions its efficacy regarding multi-organ complications.

Younger adults with SCD more likely to take hydroxyurea | ASH

Conference reports - RSi Communications
Monday 18 December 2017

Older adults’ concern about HU questions its efficacy regarding multi-organ complications.

More Conference Reports >

Featured channels

application icon

Oncology Oncology essentials all in one place

Keep up with oncology literature in minutes, every day

Get your daily dose of the latest evidence published in your cancer area of practice
Get my daily Newsletter

Univadis^®

Univadis^®, provided by MSD, brings you unbiased, relevant medical news as well as helpful resources for your daily practice at no cost.

Our Partners

Univadis^® brings together premium content publishers that deliver comprehensive and up-to-date medical information.

Contact Us

E-mail Us

Complete contact form >

MSD does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-MSD sources. Please read our Terms of Use for more information

Copyright © 2019 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. All rights reserved.